0001179110-17-013135.txt : 20171004 0001179110-17-013135.hdr.sgml : 20171004 20171004203244 ACCESSION NUMBER: 0001179110-17-013135 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171002 FILED AS OF DATE: 20171004 DATE AS OF CHANGE: 20171004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tursi James Patrick CENTRAL INDEX KEY: 0001527710 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37691 FILM NUMBER: 171123110 MAIL ADDRESS: STREET 1: 400 ALEXANDER PARK DRIVE CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aralez Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001660719 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101 CITY: MISSISSAUGA STATE: A6 ZIP: L5N 0E4 BUSINESS PHONE: 905-876-1118 MAIL ADDRESS: STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101 CITY: MISSISSAUGA STATE: A6 ZIP: L5N 0E4 4 1 edgar.xml FORM 4 - X0306 4 2017-10-02 0 0001660719 Aralez Pharmaceuticals Inc. ARLZ 0001527710 Tursi James Patrick C/O ARALEZ PHARMACEUTICALS INC., 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 ONTARIO, CANADA 0 1 0 0 Chief Medical Officer Common Shares, without par value 2017-10-02 4 S 0 9960 2.5018 D 257350 D This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 29,000 restricted stock units, which vested on October 1, 2017. 7,284 of such restricted stock units were previously granted on October 1, 2015 and 21,716 of such restricted stock units were previously granted on February 12, 2016. This transaction was executed in multiple trades at prices ranging from $2.50 to $2.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Eric L. Trachtenberg, attorney-in-fact for James P. Tursi 2017-10-04